Introduces three commercially available modalities of resistance testing and describes the data generated by each

Describes the methodologies employed by Virco to calculate fold-change values (a quantitative measure of HIV drug resistance) from its extensive correlative database of genotypes and phenotypes on clinical isolates.

Describes the data and methods used by Virco to establish the clinical cut-offs that are used to assess patient results on the virco^®TYPE HIV-1 report.

Provides a detailed explanation of how to read and use the virco^®TYPE HIV-1 Report

Provides a detailed explanation of how to read and use the virco® TYPE HIV-1 Report using a less experienced patient example.